CN104117015A - Rhizoma drynariae capsule and preparing method thereof - Google Patents

Rhizoma drynariae capsule and preparing method thereof Download PDF

Info

Publication number
CN104117015A
CN104117015A CN201410329945.8A CN201410329945A CN104117015A CN 104117015 A CN104117015 A CN 104117015A CN 201410329945 A CN201410329945 A CN 201410329945A CN 104117015 A CN104117015 A CN 104117015A
Authority
CN
China
Prior art keywords
capsule
extraction
powder
radix
extracting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410329945.8A
Other languages
Chinese (zh)
Inventor
刘方旭
修建东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
YANTAI HENGDIKE ENERGY TECHNOLOGY Co Ltd
Original Assignee
YANTAI HENGDIKE ENERGY TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by YANTAI HENGDIKE ENERGY TECHNOLOGY Co Ltd filed Critical YANTAI HENGDIKE ENERGY TECHNOLOGY Co Ltd
Priority to CN201410329945.8A priority Critical patent/CN104117015A/en
Publication of CN104117015A publication Critical patent/CN104117015A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A rhizoma drynariae capsule and a preparing method thereof are disclosed. The bone-recuperating capsule is prepared by adopting rhizoma drynariae, pseudo-ginseng, Chinese angelica, eucommia, resina draconis, cortex acanthopanacis, safflower, curcuma tuber, frankincense, myrrh, red paeony root, rhizoma atractylodes, monkshoodvine root-bark, ligusticum wallichii, and red sage root as raw materials, and by steps of smashing, extracting, mixing, preparing the capsule, sterilizing and packaging. The efficacy of the capsule can directly reach lumbar vertebra diseased regions. The capsule is capable of allowing acid calcified nucleus pulposus to be slowly melt, softened, degraded and retracted into the lumbar cavity, restoring and reinforcing broken fibrous rings, increasing the density of lumbar cartilage boards, making the disease symptoms disappeared, and allowing patients to recover.

Description

A kind of drynaria baronii capsule and preparation method thereof
Technical field
The present invention relates to the technical field of Chinese medicinal capsule, espespecially a kind of drynaria baronii capsule and preparation method thereof.
Background technology
Prolapse of lumbar intervertebral disc is one of comparatively common illness, mainly because lumbar intervertebral disc each several part, especially vertebral pulp, have after degenerative change in various degree, under the effect of external force factor, the Anular disruption of intervertebral disc, nucleus pulposus protrudes from rear or canalis spinalis from the part of breaking, cause adjacent ridge nerve root stimulated or oppress, thereby produce flank pain, a series of clinical symptoms such as side lower limb or two numbness of lower limbs, pain.
Prolapse of lumbar intervertebral disc is not only friend's person in middle and old age patent, and it has sizable threat to young friend equally.Prolapse of lumbar intervertebral disc is divided into: bulging, give prominence to, deviate from.Symptom is varied.Comprise various lumbago symptoms, patient often has waist and sacrum pain, and pain is darker, can gently can weigh.After light sitting, just produce; Severe one is unbearably painful, is unable to leave the bed, and slightly moving just pain, stands up very difficulty, agonizing.As treatment not in time, can affect people's orthobiosis, working and learning.
In recent years, for the slight patient of disease generally lie up to adopting, the method treatment such as traction therapeutic, physical therapy and massage, for the heavier many employing operation methods treatment of patient's doctor trained in Western medicine of symptom, get certain therapeutic effect, can play alleviation clinical symptoms, but cure the symptoms, not the disease, and medical expense is higher, has certain risk.
Chinese medicine is the result drawing through the human experimentation of several thousand, simultaneously just on the books from Huang di's Canon of Medicine to the understanding of prolapse of lumbar intervertebral disc symptom.Although treatment by Chinese herbs prolapse of lumbar intervertebral disc symptom can treating both the principal and secondary aspects of a disease, and side effect is little, medical expense is lower, and Chinese medicine is in use more loaded down with trivial details, needs to decoct processing, brings many inconvenience to taking of patient.Nowadays can convenient and swiftly take treatment by Chinese herbs prolapse of lumbar intervertebral disc and press symptom, become the focus that people pay close attention to always.
Summary of the invention
A kind of drynaria baronii capsule of the present invention and preparation method thereof, adopting drynaria baronii, Radix Notoginseng, Radix Angelicae Sinensis, the Cortex Eucommiae, Sanguis Draxonis, Cortex Acanthopancis, Flos Carthami, Radix Curcumae, Olibanum, Myrrha, Radix Paeoniae Rubra, Rhizoma Atractylodis, Eumeces Chinensis, Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae is raw material, prepare Gukang capsule through pulverizing, extraction, mixing, capsule processed, sterilization packaging, can realize the object for the treatment of by Chinese herbs prolapse of lumbar intervertebral disc symptom.
To achieve these goals, technical solution of the present invention is: the Chinese medicinal components of a kind of drynaria baronii capsule and preparation method thereof: drynaria baronii 10%, Radix Notoginseng 6%~8%, Radix Angelicae Sinensis 4%~6%, the Cortex Eucommiae 6%~8%, Sanguis Draxonis 4%~6%, Cortex Acanthopancis 2%~4%, Flos Carthami 4%~6%, Radix Curcumae 4%~6%, Olibanum 4%~6%, Myrrha 6%~8%, Radix Paeoniae Rubra 6%~8%, Rhizoma Atractylodis 8%~10%, Eumeces Chinensis 6%~8%, Rhizoma Chuanxiong 8%~10%, Radix Salviae Miltiorrhizae 8%~10%.
Preparation process is as follows:
(1) get the raw materials ready: Chinese medicinal components is carried out respectively to remove impurity, dry, pulverize, cross 60 mesh sieves, extracting screen underflow, in obtaining
Medicated powder;
(2) extraction: adopt supercritical extracting equipment device, Chinese medicine powder is put into respectively to supercritical CO 2in the extraction kettle of extraction equipment, add supercritical CO 2for extractant, 30 DEG C~50 DEG C of extraction temperature, extracting pressure 15Mpa~30Mpa, extraction time is 4h~6h, then adopts intensification, blood pressure lowering to separate, and collects caking product in separating still, through pulverizing 100 mesh sieves, obtains extraction powder;
(3) mix: the extraction powder of each Chinese medicinal components is packed in the efficient asymmetric mixer of V-type in proportion, turn/min of speed of agitator 12, incorporation time 8min~10 min, obtains mixed powder;
(4) load: mixed powder is added in capsule loading machine, to make every quality be 0.5g capsule;
(5) sterilization packaging: capsule is inserted and irradiated after 2~3min packaging in time under ultraviolet.
The effect of Chinese medicinal components of the present invention and effect: drynaria baronii has the kidney invigorating bone strengthening, continuous effect of hindering pain relieving, be aided with Radix Notoginseng, Radix Angelicae Sinensis, the Cortex Eucommiae, Sanguis Draxonis, Cortex Acanthopancis, Flos Carthami, Radix Curcumae, Olibanum, Myrrha, Radix Paeoniae Rubra, Rhizoma Atractylodis, Eumeces Chinensis, Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae 15 taste Chinese medicines and make capsule, 4 of each taking medicine after meales, every day 2 times, its drug effect lumbal vertebra position of can going directly, make the vertebral pulp of acid calcification slowly melt softening, degraded retracts in vertebra chamber, the fibrous ring that repairing and reinforcement breaks, increase waist cartilaginous lamina density, disease is disappeared, patient obtains rehabilitation.
Detailed description of the invention
Embodiment 1
(1) Chinese medicinal components: drynaria baronii 10%, Radix Notoginseng 8%, Radix Angelicae Sinensis 4%, the Cortex Eucommiae 8%, Sanguis Draxonis 4%, Cortex Acanthopancis 4%, Flos Carthami 6%, Radix Curcumae 4%, Olibanum 4%, Myrrha 8%, Radix Paeoniae Rubra 6%, Rhizoma Atractylodis 10%, Eumeces Chinensis 6%, Rhizoma Chuanxiong 10%, Radix Salviae Miltiorrhizae 8%.
(2) preparation process is as follows:
1. get the raw materials ready: Chinese medicinal components is carried out respectively to remove impurity, dry, pulverize, cross 60 mesh sieves, extracting screen underflow, in obtaining
Medicated powder;
2. extraction: adopt supercritical extracting equipment device, Chinese medicine powder is put into respectively to supercritical CO 2in the extraction kettle of extraction equipment, add supercritical CO 2for extractant, 30 DEG C~50 DEG C of extraction temperature, extracting pressure 15Mpa~30Mpa, extraction time is 4h~6h, then adopts intensification, blood pressure lowering to separate, and collects caking product in separating still, through pulverizing 100 mesh sieves, obtains extraction powder;
3. mix: the extraction powder of each Chinese medicinal components is packed in the efficient asymmetric mixer of V-type in proportion, turn/min of speed of agitator 12, incorporation time 8min~10 min, obtains mixed powder;
4. load: mixed powder is added in capsule loading machine, to make every quality be 0.5g capsule;
5. sterilization packaging: capsule is inserted and irradiated after 2~3min packaging in time under ultraviolet.
Embodiment 2
(1) Chinese medicinal components: drynaria baronii 10%, Radix Notoginseng 7%, Radix Angelicae Sinensis 5%, the Cortex Eucommiae 7%, Sanguis Draxonis 5%, Cortex Acanthopancis 3%, Flos Carthami 5%, Radix Curcumae 5%, Olibanum 5%, Myrrha 7%, Radix Paeoniae Rubra 7%, Rhizoma Atractylodis 9%, Eumeces Chinensis 7%, Rhizoma Chuanxiong 9%, Radix Salviae Miltiorrhizae 9%.
(2) preparation process is as follows:
1. get the raw materials ready: Chinese medicinal components is carried out respectively to remove impurity, dry, pulverize, cross 60 mesh sieves, extracting screen underflow, in obtaining
Medicated powder;
2. extraction: adopt supercritical extracting equipment device, Chinese medicine powder is put into respectively to supercritical CO 2in the extraction kettle of extraction equipment, add supercritical CO 2for extractant, 30 DEG C~50 DEG C of extraction temperature, extracting pressure 15Mpa~30Mpa, extraction time is 4h~6h, then adopts intensification, blood pressure lowering to separate, and collects caking product in separating still, through pulverizing 100 mesh sieves, obtains extraction powder;
3. mix: the extraction powder of each Chinese medicinal components is packed in the efficient asymmetric mixer of V-type in proportion, turn/min of speed of agitator 12, incorporation time 8min~10 min, obtains mixed powder;
4. load: mixed powder is added in capsule loading machine, to make every quality be 0.5g capsule;
5. sterilization packaging: capsule is inserted and irradiated after 2~3min packaging in time under ultraviolet.
Embodiment 3
(1) Chinese medicinal components: drynaria baronii 10%, Radix Notoginseng 6%, Radix Angelicae Sinensis 6%, the Cortex Eucommiae 6%, Sanguis Draxonis 6%, Cortex Acanthopancis 2%, Flos Carthami 4%, Radix Curcumae 6%, Olibanum 6%, Myrrha 6%, Radix Paeoniae Rubra 8%, Rhizoma Atractylodis 8%, Eumeces Chinensis 8%, Rhizoma Chuanxiong 8%, Radix Salviae Miltiorrhizae 10%.
(2) preparation process is as follows:
1. get the raw materials ready: Chinese medicinal components is carried out respectively to remove impurity, dry, pulverize, cross 60 mesh sieves, extracting screen underflow, in obtaining
Medicated powder;
2. extraction: adopt supercritical extracting equipment device, Chinese medicine powder is put into respectively to supercritical CO 2in the extraction kettle of extraction equipment, add supercritical CO 2for extractant, 30 DEG C~50 DEG C of extraction temperature, extracting pressure 15Mpa~30Mpa, extraction time is 4h~6h, then adopts intensification, blood pressure lowering to separate, and collects caking product in separating still, through pulverizing 100 mesh sieves, obtains extraction powder;
3. mix: the extraction powder of each Chinese medicinal components is packed in the efficient asymmetric mixer of V-type in proportion, turn/min of speed of agitator 12, incorporation time 8min~10 min, obtains mixed powder;
4. load: mixed powder is added in capsule loading machine, to make every quality be 0.5g capsule;
5. sterilization packaging: capsule is inserted and irradiated after 2~3min packaging in time under ultraviolet.
Clinical effectiveness
Adopt the present invention to treat model case 232 examples, male l14 example, women ll8 example; The oldest 65 years old, minimum 23 years old: effective percentage 95.7%.159 examples of wherein fully recovering account for 65.6%, and its symptom disappears substantially, and sign disappears, and can normally work; 63 examples that significantly take a turn for the better account for 27.1%, and it has mild sign to disappear, and does not affect live and work; 7 examples that take a turn for the better account for 3%, and its symptom and sign all take a favorable turn, cisco unity malfunction; Invalid l0 example accounts for 4.3%, and its symptom and sign changes especially.
The above; embodiment is only that the preferred embodiment of the present invention is described; not scope of the present invention is limited; under the prerequisite of spirit that does not depart from the technology of the present invention; various distortion and improvement that this area engineers and technicians make technical scheme of the present invention, all should fall in the definite protection domain of claims of the present invention.

Claims (2)

1. drynaria baronii capsule and preparation method thereof, is characterized in that: Chinese medicinal components is drynaria baronii 10%, Radix Notoginseng 6%~8%, Radix Angelicae Sinensis 4%~6%, the Cortex Eucommiae 6%~8%, Sanguis Draxonis 4%~6%, Cortex Acanthopancis 2%~4%, Flos Carthami 4%~6%, Radix Curcumae 4%~6%, Olibanum 4%~6%, Myrrha 6%~8%, Radix Paeoniae Rubra 6%~8%, Rhizoma Atractylodis 8%~10%, Eumeces Chinensis 6%~8%, Rhizoma Chuanxiong 8%~10%, Radix Salviae Miltiorrhizae 8%~10%.
2. a kind of drynaria baronii capsule according to claim 1 and preparation method thereof, is characterized in that: preparation process is as follows:
(1) get the raw materials ready: Chinese medicinal components is carried out respectively to remove impurity, dry, pulverize, cross 60 mesh sieves, extracting screen underflow, obtains Chinese medicine powder;
(2) extraction: extraction: adopt supercritical extracting equipment device, Chinese medicine powder is put into respectively to supercritical CO 2in the extraction kettle of extraction equipment, add supercritical CO 2for extractant, 30 DEG C~50 DEG C of extraction temperature, extracting pressure 15Mpa~30Mpa, extraction time is 4h~6h, then adopts intensification, blood pressure lowering to separate, and collects caking product in separating still, through pulverizing 100 mesh sieves, obtains extraction powder;
(3) mix: the extraction powder of each Chinese medicinal components is packed in the efficient asymmetric mixer of V-type in proportion, turn/min of speed of agitator 12, incorporation time 8min~10 min, obtains mixed powder;
(4) load: mixed powder is added in capsule loading machine, to make every quality be 0.5g capsule;
(5) sterilization packaging: capsule is inserted and irradiated after 2~3min packaging in time under ultraviolet.
CN201410329945.8A 2014-07-12 2014-07-12 Rhizoma drynariae capsule and preparing method thereof Pending CN104117015A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410329945.8A CN104117015A (en) 2014-07-12 2014-07-12 Rhizoma drynariae capsule and preparing method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410329945.8A CN104117015A (en) 2014-07-12 2014-07-12 Rhizoma drynariae capsule and preparing method thereof

Publications (1)

Publication Number Publication Date
CN104117015A true CN104117015A (en) 2014-10-29

Family

ID=51762795

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410329945.8A Pending CN104117015A (en) 2014-07-12 2014-07-12 Rhizoma drynariae capsule and preparing method thereof

Country Status (1)

Country Link
CN (1) CN104117015A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105106854A (en) * 2015-09-18 2015-12-02 刘迎春 Traditional Chinese medicine preparation for treating lumbar spondylosis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105106854A (en) * 2015-09-18 2015-12-02 刘迎春 Traditional Chinese medicine preparation for treating lumbar spondylosis

Similar Documents

Publication Publication Date Title
CN101422591A (en) Capsules capable of greatly improving immunity and preparation method thereof
CN103908545B (en) Drug for treating cervical and lumbar vertebra and knee hyperosteogeny and lumbar disc herniation
CN103893463A (en) Traditional Chinese medicine composition for treating lumbar disc herniation and preparation method thereof
CN103463241A (en) Traditional Chinese medicine composition for treating lumbar disc herniation
CN103893702A (en) Traditional Chinese medicine composition for treating cervical spine bone hyperplasia and preparation method thereof
CN103316192B (en) Traditional Chinese medicine foot-bathing liquid for treating lumbocrural pain and preparation method thereof
CN102441145B (en) Medicament for treating lumbar disc herniation and cervical spondylosis
CN100372551C (en) Chinese medicine for treating hyperosteogeny
CN101961400B (en) Chinese medicament for treating sciatica and preparation method and application thereof
CN103566278A (en) Pellet used for treating bone fracture
CN105343442A (en) External medicament for treating lubar intervertebral disc protrusion and preparation method thereof
CN112494625B (en) Bone rheumatism plaster and preparation method thereof
CN104117015A (en) Rhizoma drynariae capsule and preparing method thereof
CN104338089A (en) Medicament for treating cervical spondylosis and preparation method thereof
CN103263519A (en) Medicine for treating dry stool
CN102657839A (en) Traditional Chinese medicine capsule for treating coronary heart disease
CN106039244A (en) Traditional Chinese medicine for treating heumatism and preparation method
CN105687944A (en) Traditional Chinese medicine composition for treating cervical spondylosis and lumbar spondylosis
CN104127632A (en) Traditional Chinese medicine for curing lumbar spinal stenosis
CN104758916A (en) Capsules for treating backache
CN103784604A (en) Traditional Chinese medicine composition for treating protrusion of lumbar intervertebral disc, and preparation process and application thereof
CN102370837A (en) Kidney-invigorating and tendon-reinforcing capsule
CN103860914A (en) Chinese medicine composition for treating epilepsy
CN102380050A (en) Medicament for treating pain in neck, shoulders, low back and legs and preparation method thereof
CN102274455A (en) Medicament for treating cervical spondylosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20141029